Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 3 Genitourinary 3 Head & Neck 2 Gastrointestinal 2 Breast 2 Thoracic 1

Conditions

Lung Neoplasms 1332 Carcinoma, Non-Small-Cell Lung 631 Breast Neoplasms 162 Neoplasms 99 Small Cell Lung Carcinoma 93 Prostatic Neoplasms 86 Colorectal Neoplasms 79 Motor Activity 63 Colonic Neoplasms 62 Head and Neck Neoplasms 60 Esophageal Neoplasms 49 Disease 46 Pancreatic Neoplasms 45 Melanoma 41 Stomach Neoplasms 39 Urinary Bladder Neoplasms 37 Ovarian Neoplasms 37 Pleural Effusion, Malignant 36 Neoplasm Metastasis 35 Brain Neoplasms 29 Gastrointestinal Neoplasms 28 Pulmonary Disease, Chronic Obstructive 27 Anxiety Disorders 27 Lung Diseases 26 Liver Neoplasms 26 Carcinoma, Renal Cell 26 Adenocarcinoma of Lung 26 Thoracic Neoplasms 25 Mesothelioma 24 Lymphoma 24

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Heart Diseases × Thoracic × Clear all

NCT03750110 2022-05-19

YESS

University of Nottingham

Phase NA Completed

Heart Diseases, Lung Neoplasms, Respiration Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡